Company news
Transgene Biotek Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
October 29, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
October 10, 2026
Reg. 32(1) Statement Of Deviation & Variation.
October 3, 2026
Compliance-57 (5): intimation after the end of quarter
October 3, 2026
Compliance-57 (4): Prior intimation to the beginning of the quarter
October 3, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
October 3, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
October 3, 2026
Transgene Biotek Limited. Press Release Sep 25 2026
September 25, 2026
Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Company Has Received Approval From The Registrar Of Companies (ROC), Hyderabad, Telangana, For Extension Of Time
September 25, 2026
Transgene Biotek Limited. Press Release Aug 11 2026
August 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
August 11, 2026
Transgene Biotek Limited. Press Release Aug 07 2026
August 7, 2026
1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Comp
August 7, 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
August 7, 2026
Transgene Biotek Limited. Press Release Jul 23 2026
July 23, 2026
Transgene Biotek Limited. Press Release Jul 22 2026
July 22, 2026
Compliance-57 (4): Prior intimation to the beginning of the quarter
July 22, 2026
Statement Of Deviation & Variation
July 22, 2026
Compliance-57 (5): intimation after the end of quarter
July 22, 2026
Transgene Biotek Limited. Press Release Jul 13 2026
July 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
July 13, 2026
Transgene Biotek Limited. Press Release Jun 20 2026
June 20, 2026
Closure of Trading Window
June 20, 2026
Transgene Biotek Limited. Press Release Jun 02 2026
June 2, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
June 2, 2026
Transgene Biotek Limited. Press Release May 15 2026
May 14, 2026
Board Meeting Intimation for Intimation Of The Board Meeting Of The Company - This Is To Inform You That A Meeting Of Board Of Directors Of The Company Will Be Held On Friday 29Th May 2026.
May 14, 2026
Transgene Biotek Limited. Press Release Apr 13 2026
April 13, 2026
Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31St March 2026.
April 13, 2026
Compliance-57 (4): Prior intimation to the beginning of the quarter
April 13, 2026
Compliance-57 (5): intimation after the end of quarter
April 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
April 13, 2026
Transgene Biotek Limited. Press Release Feb 13 2026
February 13, 2026
Dear Sir/Madam,This Has Reference To Our Letter Dated January 28 2026.1) The Board Has Considered And Approved The Unaudited Consolidated & Stand-Alone Financial Results Of The Company, For The Quarter Ended 31.12.2025 In Accordance With The Indian A
February 13, 2026
Board Meeting Outcome for Outcome Of Board Meeting
February 13, 2026
Transgene Biotek Limited. Press Release Feb 03 2026
February 3, 2026
Declaration Under Clause 36 Of Listing Agreement With BSEPROHIBITORY ORDER NO. RRD/SRO/1166/2026/1 - SEBI
February 3, 2026
Transgene Biotek Limited. Press Release Jan 12 2026
January 12, 2026
Statement Of Deviation & Variation
January 12, 2026
Compliance-57 (5): intimation after the end of quarter
January 12, 2026
Compliance-57 (4): Prior intimation to the beginning of the quarter
January 12, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
January 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
January 12, 2026
Transgene Biotek Limited. Press Release Dec 30 2025
December 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGM
December 30, 2025
Transgene Biotek Limited. Press Release Dec 27 2025
December 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
December 27, 2025
Transgene Biotek Limited. Press Release Dec 20 2025
December 20, 2025
Closure of Trading Window
December 20, 2025
Transgene Biotek Limited. Press Release Dec 05 2025
December 5, 2025